139 related articles for article (PubMed ID: 37221449)
1. MYCN amplification in spinal ependymoma: A five-year retrospective study.
Rao S; Sugur H; Konar S; Arivazhagan A; Santosh V
Neuropathology; 2023 Dec; 43(6):457-462. PubMed ID: 37221449
[TBL] [Abstract][Full Text] [Related]
2. Spinal Cord Ependymomas With MYCN Amplification Show Aggressive Clinical Behavior.
Swanson AA; Raghunathan A; Jenkins RB; Messing-Jünger M; Pietsch T; Clarke MJ; Kaufmann TJ; Giannini C
J Neuropathol Exp Neurol; 2019 Sep; 78(9):791-797. PubMed ID: 31373367
[TBL] [Abstract][Full Text] [Related]
3. Clinically aggressive pediatric spinal ependymoma with novel MYC amplification demonstrates molecular and histopathologic similarity to newly described MYCN-amplified spinal ependymomas.
Shatara M; Schieffer KM; Klawinski D; Thomas DL; Pierson CR; Sribnick EA; Jones J; Rodriguez DP; Deeg C; Hamelberg E; LaHaye S; Miller KE; Fitch J; Kelly B; Leraas K; Pfau R; White P; Magrini V; Wilson RK; Mardis ER; Abdelbaki MS; Finlay JL; Boué DR; Cottrell CE; Ghasemi DR; Pajtler KW; Osorio DS
Acta Neuropathol Commun; 2021 Dec; 9(1):192. PubMed ID: 34895332
[TBL] [Abstract][Full Text] [Related]
4. High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma.
Raffeld M; Abdullaev Z; Pack SD; Xi L; Nagaraj S; Briceno N; Vera E; Pittaluga S; Lopes Abath Neto O; Quezado M; Aldape K; Armstrong TS; Gilbert MR
Acta Neuropathol Commun; 2020 Jul; 8(1):101. PubMed ID: 32641156
[TBL] [Abstract][Full Text] [Related]
5. MYCN immunohistochemistry as surrogate marker for MYCN-amplified spinal ependymomas.
Mohan D; Nambirajan A; Malik R; Sharma A; Suri V; Kaur K; Doddamani R; Garg A; Gupta S; Mallick S; Sharma MC
Hum Cell; 2024 May; 37(3):704-713. PubMed ID: 38411836
[TBL] [Abstract][Full Text] [Related]
6. MYCN amplification drives an aggressive form of spinal ependymoma.
Ghasemi DR; Sill M; Okonechnikov K; Korshunov A; Yip S; Schutz PW; Scheie D; Kruse A; Harter PN; Kastelan M; Wagner M; Hartmann C; Benzel J; Maass KK; Khasraw M; Sträter R; Thomas C; Paulus W; Kratz CP; Witt H; Kawauchi D; Herold-Mende C; Sahm F; Brandner S; Kool M; Jones DTW; von Deimling A; Pfister SM; Reuss DE; Pajtler KW
Acta Neuropathol; 2019 Dec; 138(6):1075-1089. PubMed ID: 31414211
[TBL] [Abstract][Full Text] [Related]
7. Ependymomas of the spinal region in adults: Clinical and pathological features and MYCN expression levels in spinal ependymomas and myxopapillary ependymomas.
Topel G; Dirilenoğlu F; Sevin İE; Kahraman A
Ann Diagn Pathol; 2024 Jun; 70():152299. PubMed ID: 38555652
[TBL] [Abstract][Full Text] [Related]
8. Pediatric spinal ependymoma with chromothripsis of chromosome 6: a case report and review of the literature.
Scott KR; Gener MA; Repnikova EA
J Med Case Rep; 2024 Feb; 18(1):95. PubMed ID: 38351155
[TBL] [Abstract][Full Text] [Related]
9. Unusual paediatric spinal myxopapillary ependymomas: Unique molecular entities or pathological variations on a theme?
Rogers S; Jones DTW; Ireland A; Gottardo NG; Endersby R
J Clin Neurosci; 2018 Apr; 50():144-148. PubMed ID: 29402569
[TBL] [Abstract][Full Text] [Related]
10. Spinal cord ependymomas in children and adolescents.
Benesch M; Frappaz D; Massimino M
Childs Nerv Syst; 2012 Dec; 28(12):2017-28. PubMed ID: 22961356
[TBL] [Abstract][Full Text] [Related]
11. A pilot study on the use of cerebrospinal fluid cell-free DNA in intramedullary spinal ependymoma.
Connolly ID; Li Y; Pan W; Johnson E; You L; Vogel H; Ratliff J; Hayden Gephart M
J Neurooncol; 2017 Oct; 135(1):29-36. PubMed ID: 28900844
[TBL] [Abstract][Full Text] [Related]
12. Prognosis by tumor location for pediatric spinal cord ependymomas.
Oh MC; Sayegh ET; Safaee M; Sun MZ; Kaur G; Kim JM; Aranda D; Molinaro AM; Gupta N; Parsa AT
J Neurosurg Pediatr; 2013 Mar; 11(3):282-8. PubMed ID: 23259510
[TBL] [Abstract][Full Text] [Related]
13. Prognosis by tumor location in adults with spinal ependymomas.
Oh MC; Kim JM; Kaur G; Safaee M; Sun MZ; Singh A; Aranda D; Molinaro AM; Parsa AT
J Neurosurg Spine; 2013 Mar; 18(3):226-35. PubMed ID: 23311515
[TBL] [Abstract][Full Text] [Related]
14. Intradural Extramedullary Nonconus Nonfilum Spinal Ependymomas: Report of a Rare Variant and Newer Insights into Their Histogenesis with Proposal of a Classification Scheme and a Management Algorithm Based on a Review of Literature.
Das KK; Attri G; Singh S; Bhaisora KS; Verma P; Jaiswal S; Jaiswal A; Behari S
World Neurosurg; 2020 Feb; 134():323-336. PubMed ID: 31682991
[TBL] [Abstract][Full Text] [Related]
15. Spinal cord ependymoma: a review of the literature and case series of ten patients.
Celano E; Salehani A; Malcolm JG; Reinertsen E; Hadjipanayis CG
J Neurooncol; 2016 Jul; 128(3):377-86. PubMed ID: 27154165
[TBL] [Abstract][Full Text] [Related]
16. Spinal tanycytic ependymoma associated with neurofibromatosis type 2.
Cepeda S; Hernández-Laín A; Munarriz PM; Martínez González MA; Lagares A
Clin Neuropathol; 2014; 33(4):311-4. PubMed ID: 24495349
[No Abstract] [Full Text] [Related]
17. Implications of DNA Methylation Classification in Diagnosing Ependymoma.
Abe E; Suzuki M; Ichimura K; Arakawa A; Satomi K; Ogino I; Hara T; Iwamuro H; Ohara Y; Kondo A
World Neurosurg; 2024 May; 185():e1019-e1029. PubMed ID: 38479644
[TBL] [Abstract][Full Text] [Related]
18. Amplification and overexpression of mdm2 gene in ependymomas.
Suzuki SO; Iwaki T
Mod Pathol; 2000 May; 13(5):548-53. PubMed ID: 10824927
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas.
Lamszus K; Lachenmayer L; Heinemann U; Kluwe L; Finckh U; Höppner W; Stavrou D; Fillbrandt R; Westphal M
Int J Cancer; 2001 Mar; 91(6):803-8. PubMed ID: 11275983
[TBL] [Abstract][Full Text] [Related]
20. Spinal ependymoma with regional metastasis at presentation.
Pencovich N; Bot G; Lidar Z; Korn A; Wostrack M; Meyer B; Bydon M; Jallo G; Constantini S
Acta Neurochir (Wien); 2014 Jun; 156(6):1215-22. PubMed ID: 24604138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
